BioLineRx Ltd (BLRX)
NASDAQ
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 4.8M | 6.86M | 5.39M | 4.94M |
Operating Income | -8.4M | -8.86M | -9.92M | -12.36M | -18.57M | -4.82M | -5.77M | -5.39M |
Pre Tax Income | -5.73M | -12.16M | -18.55M | -16.02M | -13.88M | -696k | 484k | -5.82M |
Net Income | -5.73M | -12.16M | -18.55M | -16.02M | -13.88M | -696k | 484k | -5.82M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -11.27M | -11.77M | -9.72M | -26.34M | -4.54M | -332k | 2.03M | -4.63M |
EBITDA | -8.54M | -8.6M | -9.72M | -12.14M | -11.61M | -3.93M | -5.3M | -4.55M |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.8M |
Operating Income | -16.51M | -25.24M | -25.61M | -28.11M | -22.93M | -24.78M | -29.16M | -49.7M |
Pre Tax Income | -15.84M | -24.35M | -22.96M | -25.45M | -30.02M | -27.05M | -24.95M | -60.61M |
Net Income | -15.84M | -24.35M | -22.96M | -25.45M | -30.02M | -27.05M | -24.95M | -60.61M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -0.278 | -0.232 | -0.2 | -0.149 | -0.086 | -0.038 | -0.027 | -0.056 |
EBIT | -16.3M | -25.37M | -25.47M | -28.58M | -23.49M | -24.67M | -29.91M | -49.46M |
EBITDA | -16.03M | -24.76M | -25.06M | -27.55M | -22.38M | -24.28M | -28.77M | -42.06M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.